ArticleFrontiers in oncology2022

Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study.

Chu-Lin Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.